- Home
- CLST vs PMVP Comparison
CLST vs PMVP Comparison
Compare CLST & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- PMVP
- Stock Information
- Founded
- CLST 1922
- PMVP 2013
- Country
- CLST United States
- PMVP United States
- Employees
- CLST N/A
- PMVP N/A
- Industry
- CLST
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- CLST
- PMVP Health Care
- Exchange
- CLST Nasdaq
- PMVP Nasdaq
- Market Cap
- CLST 51.9M
- PMVP 55.1M
- IPO Year
- CLST N/A
- PMVP 2020
- Fundamental
- Price
- CLST $12.50
- PMVP $1.25
- Analyst Decision
- CLST
- PMVP Strong Buy
- Analyst Count
- CLST 0
- PMVP 1
- Target Price
- CLST N/A
- PMVP $5.00
- AVG Volume (30 Days)
- CLST 17.3K
- PMVP 230.6K
- Earning Date
- CLST 07-30-2025
- PMVP 08-07-2025
- Dividend Yield
- CLST N/A
- PMVP N/A
- EPS Growth
- CLST N/A
- PMVP N/A
- EPS
- CLST 0.57
- PMVP N/A
- Revenue
- CLST $11,257,000.00
- PMVP N/A
- Revenue This Year
- CLST N/A
- PMVP N/A
- Revenue Next Year
- CLST N/A
- PMVP N/A
- P/E Ratio
- CLST $22.00
- PMVP N/A
- Revenue Growth
- CLST 200.91
- PMVP N/A
- 52 Week Low
- CLST $10.67
- PMVP $0.81
- 52 Week High
- CLST $14.23
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- CLST 55.12
- PMVP 64.21
- Support Level
- CLST $12.53
- PMVP $0.96
- Resistance Level
- CLST $12.75
- PMVP $1.36
- Average True Range (ATR)
- CLST 0.35
- PMVP 0.09
- MACD
- CLST -0.01
- PMVP 0.01
- Stochastic Oscillator
- CLST 18.78
- PMVP 72.22
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.